Awaiting product image

ORGANISATIONAL HAZARDS IN BIOTECHNOLOGY — TOWARDS A NEW RISK ASSESSMENT PROGRAM

£0.00

Great progress in the field of recombinant DNA technology has masked concern about the safety of the procedures involved. It seems that those carrying out oncogene research using these techniques may be exposed to considerable danger of contracting cancer. A thorough program to assess the risks involved is required to replace the complacency of ignorance which now exist, and it is required before rather than after damage is done.

SKU: 0810-90288629020 Category: Tag:

Description

By Ditta Bartels

Great progress in the field of recombinant DNA technology has masked concern about the safety of the procedures involved. It seems that those carrying out oncogene research using these techniques may be exposed to considerable danger of contracting cancer. A thorough program to assess the risks involved is required to replace the complacency of ignorance which now exist, and it is required before rather than after damage is done.

page: 272 – 287
Prometheus: Critical Studies in Innovation
Volume 4, Issue 2

SKU: 0810-90288629020

Related products